Shengnuo Biotech announced that Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration. The drug's specification is 290 μg, and the registration classification is 4 types of chemicals. It has been approved for registration and issued a drug registration certificate.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.